FDA approves Lupin’s generic AdcircaThe Food and Drug Administration has cleared Lupin's generic Adcirca, which had a market value of about $474.3 million for the year ended December 2018. Camber launches generic AdcircaCamber's generic Adcirca is indicated to treat pulmonary arterial hypertension. Perrigo gets FDA nod for generic Zovirax Perrigo is set to launch generic Zovirax cream, which had a market value of about $92 million for the year ended December 2018. Lupin launches generic Anafranil Lupin is introducing generic Anafranil, which has a market value of roughly $6.2 million. Camber launches generic Norco Camber's generic Norco is indicated to relieve moderate-to-severe pain. Dr. Reddy's names North American generics head Dr. Reddy's has brought Marc Kikuchi onboard from Zydus Pharmaceuticals, naming him CEO, North America generics. USP launches its Generics Access Plan USP's Generics Access Plan intends to facilitate generics competition by collaborating with the Food and Drug Administration to develop and revise quality standards. FDA head renews push for generics competition The FDA is continuing its push to increase development and approval of generics and biosimilars. FDA OKs Mylan's Wixela Inhub, the first generic Advair Diskus Mylan’s generic Advair Diskus is the first generic drug product approved for one of the most commonly prescribed asthma and COPD inhalers. Fresenius Kabi introduces leucovorin calcium injection Fresenius Kabi's leucovorin calcium injection is the only liquid presentation of leucovorin available. First Previous 183 184 185 186 187 Next Last